Impact of combination of PSK with TGF-beta inhibitor on anti-tumor immunity

被引：0
|
作者：
Hiroaki, Tanaka
Yamazoe, Sadaaki
Lwauchi, Takehiko
Muguruma, Kazuya
Kubo, Naoshi
Kato, Yukihiro
Morinnoto, Junya
Kashiwagi, Shinichiro
Fuyuhiro, Yuhiko
Noda, Eiji
Amano, Ryosuke
Inoue, Toru
Yamada, Nobuya
Maeda, Kiyoshi
Ohira, Masaichi
Hirakawa, Kosei
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-5603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5603
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Oral TGF-beta receptor1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity
    Choi, Sung Hee
    Myers, Jay
    Tomchuck, Suzanne
    Bonner, Melissa
    Eid, Saada
    Kingsley, Daniel
    VanHeyst, Kristen
    Kim, Seong-Jin
    Kim, Byung-Gyu
    Huang, Alex Y.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] TGF-Beta: a Master Switch in Tumor Immunity
    Gigante, Margherita
    Gesualdo, Loreto
    Ranieri, Elena
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (27) : 4126 - 4134
  • [3] TGF-beta REGULATES ANTI-VIRAL IMMUNITY
    Garidou, Lucile
    Phi Truong
    McGavern, Dorian
    FASEB JOURNAL, 2008, 22
  • [4] STIMULATION OF ANTITUMOR IMMUNITY BY TGF-BETA GENETIC-MODIFICATION OF MURINE TUMOR TO EXPRESS TGF-BETA INDUCES TUMOR-REGRESSION
    KARP, SE
    CHAN, HL
    HIER, MP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 114 - 114
  • [5] Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
    Holmgaard, Rikke B.
    Schaer, David A.
    Li, Yanxia
    Castaneda, Stephen P.
    Murphy, Mary Y.
    Xu, Xiaohong
    Inigo, Ivan
    Dobkin, Julie
    Manro, Jason R.
    Iversen, Philip W.
    Surguladze, David
    Hall, Gerald E.
    Novosiadly, Ruslan D.
    Benhadji, Karim A.
    Plowman, Gregory D.
    Kalos, Michael
    Driscoll, Kyla E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [6] TUMOR PROMOTING ACTIVITY OF TGF-BETA
    HAMEL, E
    KATOH, F
    MULLER, G
    BIRCHMEIER, W
    YAMASAKI, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1758 - 1759
  • [7] Activation of NK and CD8+T-Cells with a Novel IL-15 and TGF-Beta Receptor Fusion Protein Confers Anti-Tumor Immunity
    Ng, Spencer
    Deng, Jiusheng
    Chinndurai, Raghavan
    Yuan, Shala
    Pennati, Andrea
    Galipeau, Jacques
    BLOOD, 2015, 126 (23)
  • [8] STRUCTURE AND ANTI-TUMOR EFFECT OF PSK(KRESTIN) - MECHANISTIC ASPECTS OF THE ANTI-TUMOR ACTIVITY
    MUTO, S
    KOBAYASHI, A
    OHARA, M
    MATSUNAGA, K
    IKUZAWA, M
    FURUSHO, T
    YOSHIKUMI, C
    HOTTA, T
    YANAGISAWA, M
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1982, 4 (04): : 308 - 308
  • [9] Induction of anti-tumor immunity by anti-tumor monoclonal antibodies
    Dhodapkar, Madhav V.
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 635 - 635
  • [10] Anti-tumor effects in combination with PARP inhibitor and DNMT inhibitor in ovarian cancer
    Lee, Jeong-Won
    Jeong, Soo Young
    Ryu, Ji Yoon
    Lee, Yoo-Young
    Esun, Paik
    CANCER RESEARCH, 2019, 79 (13)
12345